BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28790116)

  • 1. Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment.
    Martinez-Garcia E; Lesur A; Devis L; Cabrera S; Matias-Guiu X; Hirschfeld M; Asberger J; van Oostrum J; Casares de Cal MLÁ; Gómez-Tato A; Reventos J; Domon B; Colas E; Gil-Moreno A
    Clin Cancer Res; 2017 Nov; 23(21):6458-6467. PubMed ID: 28790116
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples.
    Martinez-Garcia E; Lesur A; Devis L; Campos A; Cabrera S; van Oostrum J; Matias-Guiu X; Gil-Moreno A; Reventos J; Colas E; Domon B
    Oncotarget; 2016 Aug; 7(33):53102-53115. PubMed ID: 27447978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of endometrial cancer from uterine aspirates.
    Perez-Sanchez C; Colas E; Cabrera S; Falcon O; Sanchez-del-Río A; García E; Fernández-de-Castillo L; Muruzabal JC; Alvarez E; Fiol G; González C; Torrejón R; Moral E; Campos M; Repollés M; Carreras R; Jiménez-López J; Xercavins J; Aibar E; Perdones-Montero A; Lalanne E; Palicio M; Maes T; Rosell-Vives E; Nieto C; Ortega A; Pedrola N; Llauradó M; Rigau M; Doll A; Abal M; Ponce J; Gil-Moreno A; Reventós J
    Int J Cancer; 2013 Nov; 133(10):2383-91. PubMed ID: 23649867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
    Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
    Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of cervical cytology improves diagnosis of endometrial cancer: A prospective multicentre cohort study.
    Reijnen C; van der Putten LJM; Bulten J; Snijders MPLM; Küsters-Vandevelde HVN; Sweegers S; Vos MC; van der Wurff AAM; Ligtenberg MJL; Massuger LFAG; Eijkelenboom A; Pijnenborg JMA
    Int J Cancer; 2020 May; 146(9):2628-2635. PubMed ID: 31523803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of histological types of endometrial cancer by endometrial cytology.
    Okadome M; Saito T; Nishiyama N; Ariyoshi K; Shimamoto K; Shimada T; Kodama K; Imamura S; Nishiyama K; Taguchi K
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1931-9. PubMed ID: 25056473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Heterogeneity in Endometrial Carcinoma: Practical Consequences.
    Gatius S; Cuevas D; Fernández C; Roman-Canal B; Adamoli V; Piulats JM; Eritja N; Martin-Satue M; Moreno-Bueno G; Matias-Guiu X
    Pathobiology; 2018; 85(1-2):35-40. PubMed ID: 28614814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
    Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
    J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program.
    Angioli R; Capriglione S; Scaletta G; Aloisi A; Miranda A; De Cicco Nardone C; Terranova C; Plotti F
    Tumour Biol; 2016 Apr; 37(4):4973-8. PubMed ID: 26531723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted MR imaging of uterine endometrial cancer.
    Tamai K; Koyama T; Saga T; Umeoka S; Mikami Y; Fujii S; Togashi K
    J Magn Reson Imaging; 2007 Sep; 26(3):682-7. PubMed ID: 17729360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotaxin is a novel molecular identifier of type I endometrial cancer.
    Mazzocca A; Schönauer LM; De Nola R; Lippolis A; Marrano T; Loverro M; Sabbà C; Di Naro E
    Med Oncol; 2018 Oct; 35(12):157. PubMed ID: 30374843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to recognize preoperatively high-risk endometrial carcinoma is associated with a poor outcome.
    Di Cello A; Rania E; Zuccalà V; Venturella R; Mocciaro R; Zullo F; Morelli M
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():153-60. PubMed ID: 26409060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer.
    Wang Q; Xu K; Tong Y; Dai X; Xu T; He D; Ying J
    J Cell Mol Med; 2020 Apr; 24(8):4533-4546. PubMed ID: 32150330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 is significantly associated with stage of tumor and predicts poor survival in endometrial carcinoma patients.
    Khabaz MN; Abdelrahman AS; Butt NS; Al-Maghrabi B; Al-Maghrabi J
    Ann Diagn Pathol; 2017 Oct; 30():47-51. PubMed ID: 28965628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histotype-genotype correlation in 36 high-grade endometrial carcinomas.
    Hoang LN; McConechy MK; Köbel M; Han G; Rouzbahman M; Davidson B; Irving J; Ali RH; Leung S; McAlpine JN; Oliva E; Nucci MR; Soslow RA; Huntsman DG; Gilks CB; Lee CH
    Am J Surg Pathol; 2013 Sep; 37(9):1421-32. PubMed ID: 24076778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in endometrial cancer protein biomarkers for use in the clinic.
    Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
    Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
    Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
    Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating tumour cells may add value in endometrial cancer management.
    Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.